Safety Concerns Linked to Herbal Medicine Use in Cancer

This article originally appeared here.
Share this content:
Safety Concerns Linked to Herbal Medicine Use in Cancer
Safety Concerns Linked to Herbal Medicine Use in Cancer

WEDNESDAY, Dec. 2, 2015 (HealthDay News) -- For patients with cancer, use of herbal medicine has associated safety-related concerns, including direct toxic effects and increased chemosensitivity of cancer cells, according to a study published online Nov. 24 in Cancer.

Eran Ben-Arye, M.D., from the Lin Medical Center in Haifa, Israel, and colleagues examined the use of herbal medicine by Middle Eastern patients with cancer, using a 17-item questionnaire that was administered by oncology health care professionals (HCPs). The literature was reviewed to assess potential negative effects associated with herbal products identified by the study HCPs.

The researchers found that 44 herbal and three non-herbal nutritional supplements were identified by 339 HCPs who completed the study questionnaire (response rate, 80.3 percent). Twenty-nine products had associated safety-related concerns, including herb-drug interactions with altered pharmacodynamics, direct toxic effects, and increased in vitro response of cancer cells to chemotherapy (15, 18, and seven herbs, respectively).

"Oncology HCPs working in countries in which herbal medicine use is prevalent need to better understand the implications of this practice," the authors write. "The presence of integrative physicians with training in complementary and traditional medicine can help patients and their HCPs reach an informed decision regarding the safety and effective use of these products."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »